820
Views
40
CrossRef citations to date
0
Altmetric
Case Reports

Cefepime neurotoxicity despite renal adjusted dosing

, &
Pages 827-829 | Received 06 Apr 2011, Accepted 11 Apr 2011, Published online: 23 May 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Alan Abdulla, Tim M.J. Ewoldt, Ilse M. Purmer, Anouk E. Muller, Diederik Gommers, Henrik Endeman & Birgit C.P. Koch. (2021) A narrative review of predictors for β-lactam antibiotic exposure during empirical treatment in critically ill patients. Expert Opinion on Drug Metabolism & Toxicology 17:4, pages 359-368.
Read now
Zhenbao Liu, Chunyan Wang, Yanfei Liu & Dongming Peng. (2017) Cefepime loaded O-carboxymethyl chitosan microspheres with sustained bactericidal activity and enhanced biocompatibility. Journal of Biomaterials Science, Polymer Edition 28:1, pages 79-92.
Read now
Dénes Zádori, Gábor Veres, Levente Szalárdy, Péter Klivényi & László Vécsei. (2015) Drug-induced movement disorders. Expert Opinion on Drug Safety 14:6, pages 877-890.
Read now
Tomotaka Ugai, Kurimi Morisaki, Kenji Tsuda, Hiroyuki Sugihara, Yuhki Nishida, Masayuki Yamakura, Masami Takeuchi & Kosei Matsue. (2014) Cefepime-induced encephalopathy in patients with haematological malignancies: Clinical features and risk factors. Scandinavian Journal of Infectious Diseases 46:4, pages 272-279.
Read now
JiSheng Zhang, CongYang Huang, Hong Li, Qiang Yao, Jun Xu, JiangZi Yuan, JiaQi Qian & BeiYan Bao. (2013) Antibiotic-induced neurotoxicity in dialysis patients: a retrospective study. Renal Failure 35:6, pages 901-905.
Read now

Articles from other publishers (35)

Malarkodi SuppamutharwyamTunku Muzafar Shah. (2023) Cefepime‐induced delirium. Progress in Neurology and Psychiatry 27:4, pages 30-34.
Crossref
T. N. Pushkar, P. N. Vlasov, A. I. Belyakova-Bodina & A. G. Broutian. (2023) Cefepime-induced encephalopathy. Neurology, Neuropsychiatry, Psychosomatics 15:3, pages 76-81.
Crossref
Edward T. Qian, Li Wang, Joanna L. Stollings, Jonathan D. Casey, Todd W. Rice & Matthew W. Semler. (2023) Piperacillin-Tazobactam Versus Anti-Pseudomonal Cephalosporins and Renal and Neurologic Outcomes in Critically Ill Adults: A Secondary Analysis of the SMART Trial. Journal of Intensive Care Medicine.
Crossref
Saki Bussaka, Takaichi Suehiro, Koji Mitsuiki, Takato Morioka, Tadahisa Shono, Fujio Fujiki & Toshiaki Nakano. (2023) Non-convulsive status epilepticus possibly induced by a rapid correction of severe hyperkalemia: a case report and literature review. BMC Nephrology 24:1.
Crossref
Erfan Alijani, Sonal Sekhar Miraj, Shilia Jacob Kurian, Mahadev Rao & Kavitha Saravu. (2023) Cefepime-induced Neurotoxicity: A Retrospective Cohort Study in a South-Indian Tertiary Healthcare Facility. Current Drug Safety 18:1, pages 69-78.
Crossref
Gökçe Öztürk & Dilek Kul. (2023) Comparison of carbon paste and boron-doped diamond electrodes for determination of cefepime in pharmaceutical dosage forms and biological samples. Diamond and Related Materials 131, pages 109532.
Crossref
Gozun Maan, Koichi Keitoku, Nobuhiko Kimura, Haruki Sawada, Andrew Pham, Jihun Yeo, Hideharu Hagiya & Yoshito Nishimura. (2022) Cefepime-induced neurotoxicity: systematic review. Journal of Antimicrobial Chemotherapy 77:11, pages 2908-2921.
Crossref
Marco A. PATRUNO, Silvano DRAGONIERI, Francesca ADDANTE, Stefano PATRUNO, Piero PORTINCASA & Pierluigi CARRATÙ. (2022) A successfully home-treated adverse reaction to cefepime in a geriatric patient. Minerva Respiratory Medicine 61:3.
Crossref
Natalie A. Haddad, Diana J. Schreier, Jennifer E. Fugate, Ognjen Gajic, Sara E. Hocker, Calvin J. Ice, Sarah B. Leung, Kristin C. Mara, Alejandro A. Rabinstein, Andrew D. Rule & Erin F. Barreto. (2022) Incidence and Predictive Factors Associated with Beta-Lactam Neurotoxicity in the Critically Ill: A Retrospective Cohort Study. Neurocritical Care 37:1, pages 73-80.
Crossref
Gwendolyn M. Pais, Jack Chang, Erin F. Barreto, Gideon Stitt, Kevin J. Downes, Mohammad H. Alshaer, Emily Lesnicki, Vaidehi Panchal, Maria Bruzzone, Argyle V. Bumanglag, Sara N. Burke & Marc H. Scheetz. (2022) Clinical Pharmacokinetics and Pharmacodynamics of Cefepime. Clinical Pharmacokinetics 61:7, pages 929-953.
Crossref
Michael L. Behal, Jenni K. Thomas, Melissa L. Thompson Bastin & Breanne M. Mefford. (2021) Cefepime Induced Neurotoxicity Following A Regimen Dose-Adjusted for Renal Function: Case Report and Review of the Literature. Hospital Pharmacy 57:3, pages 385-391.
Crossref
Mosunmoluwa Oyenuga, Abayomi Oyenuga, Abdul Rauf, Omotola Balogun & Niranjan Singh. (2021) New Onset Non-Convulsive Status Epilepticus Despite Cefepime Renal Dose Adjustment. Cureus.
Crossref
Tarun D. Singh, John C. O’Horo, Courtney N. Day, Jay Mandrekar & Alejandro A. Rabinstein. (2020) Cefepime is Associated with Acute Encephalopathy in Critically Ill Patients: A Retrospective Case–Control Study. Neurocritical Care 33:3, pages 695-700.
Crossref
Pitchaya Wanleenuwat, Nanthushan Suntharampillai & Piotr Iwanowski. (2020) Antibiotic-induced epileptic seizures: mechanisms of action and clinical considerations. Seizure 81, pages 167-174.
Crossref
Luis Rafael Moscote-Salazar, Amrita Ghosh, Ranabir Pal, Sumit Raj, Md Moshiur Rahman & Amit Agrawal. (2020) Neurotoxicity Associated with Cefepime: An Update to Neurocritical Care: A Narrative Review. Journal of Translational Critical Care Medicine 2:2, pages 28-35.
Crossref
Se-Jin Lee. (2019) Cefepime-induced neurotoxicity. Journal of Neurocritical Care 12:2, pages 74-84.
Crossref
Ramadan Ali, Hassan Refat H. Ali, Hany A. Batakoushy, Sayed M. Derayea & Mohamed M. Elsutohy. (2019) A reductant colorimetric method for the rapid detection of certain cephalosporins via the production of gold and silver nanoparticles. Microchemical Journal 146, pages 864-871.
Crossref
Jessica J. Grahl, Joanna L. Stollings, Shayan Rakhit, Anna K. Person, Li Wang, Jennifer L. Thompson, Pratik P. Pandharipande, E. Wesley Ely & Mayur B. Patel. (2018) Antimicrobial exposure and the risk of delirium in critically ill patients. Critical Care 22:1.
Crossref
Ying Han, Yangmin Zheng, Jingpu Zhang & Changqin Hu. (2018) Neurobehavioral Effects of Cephalosporins: Assessment of Locomotors Activity, Motor and Sensory Development in Zebrafish. Frontiers in Pharmacology 9.
Crossref
Lauren E. Payne, David J. Gagnon, Richard R. Riker, David B. Seder, Elizabeth K. Glisic, Jane G. Morris & Gilles L. Fraser. (2017) Cefepime-induced neurotoxicity: a systematic review. Critical Care 21:1.
Crossref
Samuel Deshayes, Antoine Coquerel & Renaud Verdon. (2017) Neurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review. Drug Safety 40:12, pages 1171-1198.
Crossref
Ayesha A Appa, Rupali Jain, Robert M Rakita, Shahin Hakimian & Paul S Pottinger. (2017) Characterizing Cefepime Neurotoxicity: A Systematic Review. Open Forum Infectious Diseases 4:4.
Crossref
Cigdem Isitan, Andrew Ferree & Anna DePold Hohler. (2017) Cefepime induced neurotoxicity: A case series and review of the literature. eNeurologicalSci 8, pages 40-43.
Crossref
Lee-Ann Wagner & Jeffrey C. Fink. (2017) Ensuring Patient Safety During the Transition to ESRD. Seminars in Nephrology 37:2, pages 194-208.
Crossref
Stijn Jonckheere, Nikolaas De Neve, Hans De Beenhouwer, Mario Berth, An Vermeulen, Jan Van Bocxlaer & Pieter Colin. (2016) A model-based analysis of the predictive performance of different renal function markers for cefepime clearance in the ICU. Journal of Antimicrobial Chemotherapy 71:9, pages 2538-2546.
Crossref
Holly Lindsay, Stephanie Gruner & Julienne Brackett. (2016) Cefepime-Induced Neurotoxicity Despite Dose Adjustment for Renal Disease: A Brief Report and Review of the Literature. Journal of the Pediatric Infectious Diseases Society, pages piw022.
Crossref
Yusuke Toda, Mineo Yamazaki, Tomohiro Ota, Yosuke Fujisawa & Kazumi Kimura. (2016) A case of Cefepime encephalopathy, being difficult to distinguish from non-convulsive status epilepticus during the treatment of bacterial meningitis. Rinsho Shinkeigaku 56:10, pages 678-683.
Crossref
Young R. Lee, Danni McMahan, Catherine McCall & Gregory K. Perry. (2015) Complicated Intra-Abdominal Infections: The Old Antimicrobials and the New Players. Drugs 75:18, pages 2097-2117.
Crossref
Mieke Carlier, Veronique Stove, Steven C. Wallis, Jan J. De Waele, Alain G. Verstraete, Jeffrey Lipman & Jason A. Roberts. (2015) Assays for therapeutic drug monitoring of β-lactam antibiotics: A structured review. International Journal of Antimicrobial Agents 46:4, pages 367-375.
Crossref
Mieke Carlier, Jason A. Roberts, Veronique Stove, Alain G. Verstraete, Jeffrey Lipman & Jan J. De Waele. (2015) A Simulation Study Reveals Lack of Pharmacokinetic/Pharmacodynamic Target Attainment in De-escalated Antibiotic Therapy in Critically Ill Patients. Antimicrobial Agents and Chemotherapy 59:8, pages 4689-4694.
Crossref
Laila-Yasmin Mani, Sébastien Kissling, Dragana Viceic, Bruno Vogt, Michel Burnier, Thierry Buclin & Delphine Renard. (2015) Intermittent hemodialysis treatment in cefepime-induced neurotoxicity: Case report, pharmacokinetic modeling, and review of the literature. Hemodialysis International 19:2, pages 333-343.
Crossref
Marjorie Beumier, Giuseppe Casu, Maya Hites, Lucie Seyler, Frederic Cotton, Jean-Louis Vincent, Frédérique Jacobs & Fabio Taccone. (2014) β-lactam antibiotic concentrations during continuous renal replacement therapy. Critical Care 18:3, pages R105.
Crossref
Steven W. Johnson & D. Byron May. (2014) Ceftaroline. Infectious Diseases in Clinical Practice 22:1, pages 8-17.
Crossref
Jennifer E Fugate, Ejaaz A Kalimullah, Sara E Hocker, Sarah L Clark, Eelco FM Wijdicks & Alejandro A Rabinstein. (2013) Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy. Critical Care 17:6.
Crossref
Akihiro Tanaka, Kenshi Takechi, Shinichi Watanabe, Mamoru Tanaka, Katsuya Suemaru & Hiroaki Araki. (2013) Comparison of the prevalence of convulsions associated with the use of cefepime and meropenem. International Journal of Clinical Pharmacy 35:5, pages 683-687.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.